EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis and Biological Evaluation of Ethyl 5‐(1‐benzyl‐1 H ‐indol‐5‐yl) Isoxazole‐3‐Carboxylates as Antimycobacterial Agents

Rani Bandela, Santosh Kumar Sahoo, Atri Mukhopadhyay, Mohmmad Imran, Anuradha Singampalli, Sarvan Maddipatla, Sri Mounika Bellapukonda, Devdhar Panchal, Srinivas Nanduri iD, Arunava Dasgupta, Sidharth Chopra, Venkata Madhavi Yaddanapudi iD

ChemMedChem · 2025

DOI: 10.1002/cmdc.202400902 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Rani Bandela und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Address 1Balanagar, Hyderabad, 500037, Telangan…. Hauptthemen laut MEDLINE: Drug Design, Mycobacterium tuberculosis, Antitubercular Agents, Isoxazoles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The continued prevalence of drug‐resistant Mycobacterium tuberculosis (Mtb) strains, particularly against first‐line antitubercular (anti‐TB) drugs, presents an impending public health threat that necessitates the exploration and development of New Chemical Entities (NCEs). In search of new anti‐TB leads, a library of ethyl 5‐(1‐benzyl‐1 H ‐indol‐5‐yl) isoxazole‐3‐carboxylates were generated through a strategy of scaffold hopping from the proven isoxazole‐3‐carboxylate‐based anti‐TB pharmacophore. We evaluated their antibacterial potential against a panel of pathogenic bacteria and Mtb H 37 Rv strains. The majority of the compounds exhibited notable in vitro efficacy against the H 37 Rv strains (MIC 0.25 to 16 μ g/mL) and were not cytotoxic with a Selectivity Index (SI) >10. Compound 5e (3,4‐dichlorobenzyl substituent) was found to be optimally active in the lot (MIC 0.25 μ g/mL) and SI >200. It also displayed equipotent activity against drug‐resistant Mtb (DR‐ Mtb ) strains. In addition, it demonstrated concentration‐dependent bactericidal activity in a time‐kill kinetic assay similar to first‐line anti‐TB drugs besides exhibiting synergistic activity with Streptomycin. Moreover, it complies with the drug‐likeness characteristic, making it a promising candidate for further exploration as a probable anti‐TB lead.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DesignMycobacterium tuberculosisAntitubercular AgentsIsoxazolesCarboxylic AcidsAnti-Bacterial AgentsIndolesMicrobial Sensitivity TestsStructure-Activity RelationshipMolecular StructureDose-Response Relationship, DrugHumans

Stichwörter der Autor:innen

Anti-tubercularBactericidalDrug-resistanceIndoleIsoxazoleStructural-Activity RelationshipSynergistic activityTime-kill kinetics

Substanzen

Antitubercular AgentsIsoxazolesCarboxylic AcidsAnti-Bacterial AgentsIndoles

Autor:innen und Institutionen

  • Department of Chemical Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Address 1Balanagar, Hyderabad, 500037, Telangana, India.
  • School of Pharmacy, GITAM (Deemed to be university), Visakhapatnam, 530045, Andhra Pradesh, India.
  • Division of Microbiology and Immunology, CSIR-Central Drug Research Institute, Sitapur Road, Sector 10, Janakipuram Extension, Lucknow, 226031, Uttar Pradesh, India.
  • AcSIR: Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.

ORCID-Profile: Srinivas Nanduri, Venkata Madhavi Yaddanapudi

Zitieren

APA

Bandela, R., Sahoo, S. K., Mukhopadhyay, A., Imran, M., Singampalli, A., Maddipatla, S., Bellapukonda, S. M., Panchal, D., Nanduri, S., Dasgupta, A., Chopra, S., & Yaddanapudi, V. M. (2025). Design, Synthesis and Biological Evaluation of Ethyl 5‐(1‐benzyl‐1 H ‐indol‐5‐yl) Isoxazole‐3‐Carboxylates as Antimycobacterial Agents. ChemMedChem. https://doi.org/10.1002/cmdc.202400902

Vancouver

Bandela R, Sahoo SK, Mukhopadhyay A, Imran M, Singampalli A, Maddipatla S, et al. Design, Synthesis and Biological Evaluation of Ethyl 5‐(1‐benzyl‐1 H ‐indol‐5‐yl) Isoxazole‐3‐Carboxylates as Antimycobacterial Agents. ChemMedChem. 2025. doi:10.1002/cmdc.202400902

BibTeX
@article{Bandela2025,
  author = {Bandela, Rani and Sahoo, Santosh Kumar and Mukhopadhyay, Atri and Imran, Mohmmad and Singampalli, Anuradha and Maddipatla, Sarvan and Bellapukonda, Sri Mounika and Panchal, Devdhar and Nanduri, Srinivas and Dasgupta, Arunava and Chopra, Sidharth and Yaddanapudi, Venkata Madhavi},
  title = {Design, Synthesis and Biological Evaluation of Ethyl 5‐(1‐benzyl‐1 H ‐indol‐5‐yl) Isoxazole‐3‐Carboxylates as Antimycobacterial Agents},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202400902}
}
Kostenlos starten →